Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An exciting research culture event on 17 October 2025 highlighted an ongoing pilot mentorship programme in the department, developed and led by the WICN group.

Melanie Fleming, Andrea Kusec, Manjiri Gokhale Joshi and other attendees who join the event

A survey carried out by WICN in 2023 found a desire for support and mentorship that would help individuals further their careers. The continued need to improve support for women is motivated by the low number of female academics (clinician and non-clinician) advancing to senior positions.  

The WICN 12-month pilot mentorship is the only mentorship programme available in the department. It specifically aims to addresses a gap in pastoral support identified by female clinician and non-clinician academics in NDCN. 

Following on from the programme launch in March, over 30 people attended this event, including mentees and mentors from the department, mentors external to Oxford, and others interested in career development, ranging from DPhil students to PIs. 

Get involved!

WICN welcomes all who aim to achieve better a working environment for female clinician and non-clinician academics at NDCN and as a consequence provides a stepping stone to improve NDCN working culture for everyone. 

If you are interested in hearing more about WICN and joining in WICN activities, please get in touch via Eugenie.Lagrange@ndcn.ox.ac.uk 

 

 

Read the full story on the Nuffield Department of Clinical Neurosciences website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.